Researcher journeys
Impact Stories
Read more in the stories below about how UniQuest is partnering with UQ researchers to deliver solutions for a better world.
Contact Us
UniQuest commercialises UQ research to create change. Speak to us about commercialising your research ideas today.
Researchers FAQ
General Questions
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Agreements
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?
Commercialisation
Our offering to UQ
If you are employed at The University of Queensland, we can work with you to
identify, protect and commercialise your intellectual property.
Startups and spin-outs
Access to industry
Licensing
Drug discovery and development - QEDDI
IP protection
and management
Business
development
Contact our team
We have market-facing staff with industry experience, embedded in UQ’s faculties and institutes
Staff of UQ’s Faculty of Business, Economics and Law can contact our Social and Behavioural Sciences Team, led by Anne Bannister.
Staff of the Faculty of Engineering, Architecture and Information Technology can contact our Physical Sciences Team, led by Colin Davies.
Staff from UQ’s Faculty of Health and Behavioural Sciences can contact UniQuest’s Life Sciences Team, led by Craig Belcher.
Staff from the School of Nursing, Midwifery and Social Work and the School of Psychology can contact our Social and Behavioural Sciences Team, led by Anne Bannister.
Staff of UQ’s Faculty of Humanities and Social Sciences can contact our Social and Behavioural Sciences Team, led by Anne Bannister.
Staff from UQ’s Faculty of Medicine are invited to contact our Life Sciences Team, led by Craig Belcher.
Staff from UQ’s Faculty of Science can contact either our Life Sciences Team led by Craig Belcher, or our Physical Sciences Team, led by Colin Davies.
Staff from the Australian Institute for Bioengineering and Nanotechnology can contact our Life Sciences Team, led by Craig Belcher.
UQ staff at the Frazer Institute can contact our Life Sciences Team, led by Craig Belcher.
Staff of the Global Change Institute can contact our Physical Sciences Team, led by Colin Davies.
Staff from the Institute for Molecular Bioscience can contact our Life Sciences Team, led by Craig Belcher.
Staff from the Institute for Social Science Research can contact our Social and Behavioural Sciences Team, led by Anne Bannister.
Staff from the Mater Research Institute – UQ (MRI-UQ) can contact our Life Sciences Team, led by Craig Belcher.
UQ staff at the Queensland Alliance for Agriculture and Food Innovation (QAAFI) can contact our Life Sciences Team, led by Craig Belcher.
Staff from the Queensland Brain Institute can contact our Life Sciences Team, led by Craig Belcher.
Staff from the Sustainable Minerals Institute can contact our Physical Sciences Team, led by Colin Davies.
Workshops and Events
Find out more about UniQuest’s Research Commercialisation Workshops and industry events.
Researchers
Australia’s leading research commercialisation company
UniQuest is the commercialisation company of The University of Queensland (UQ).
In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property (IP). Established in 1984, UniQuest’s commercialisation track record positions UQ as the leader of research commercialisation in Australasia.
Startups and spin-outs
Access to capital
Licensing
Drug discovery and development - QEDDI
IP protection
and management
Commercial
negotiation
News
The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.
The Queensland Emory Drug Discovery Initiative (QEDDI) will partner with research groups from across Australia who can benefit from its drug discovery services after receiving $1.9m from Therapeutic Innovation Australia (TIA) through the NCRIS.
QEDDI, which is managed by UQ’s commercialisation company UniQuest, has previously only made its services available to researchers at UQ.
Events
Industry Connect
Industry Connect events enable pre-qualified collaborations between researchers and industry.
Workshop
Research Commercialisation Workshops
Are you an early-career researcher? Want to make an impact?
We hold free, two-day workshops focussing on intellectual property and commercialisation.
Impact Stories
From idea to impact, UniQuest commercialises UQ research to create change.
Gardasil®: A global solution to eradicating cervical cancer
From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to an approximate 90 per cent decrease in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.
Encapsulated probiotic drink a world first
The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.
Bringing the benefits of positive parenting and healthy communities to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.
Available technologies
Our specialised team delivers the highest quality commercialisation expertise and can help you access the world class research, resources and intellectual property of UQ. We have a suite of available technologies and discoveries that could give your business an innovative edge.
The UniQuest Extension Fund
The UniQuest Extension Fund is a $32 million investment fund designed to support the start-up ecosystem at The University of Queensland (UQ).
The Fund will provide capital as well as skills and connections to help UQ start-up companies grow their teams, develop commercial-grade products and services, and drive customer acquisition and global expansion.
Investments will be made across three phases of the funding lifecycle of start-up companies:
Pre-seed
$2 million reserve
Initial investment in a project opportunity that has commercial potential prior to start-up company formation
Seed
$10 million reserve
Foundation investment in a start-up company
Follow-on
$20 million reserve
Subsequent investments in a start-up company
Sources of commercial opportunity
Student start-ups
Research IP start-ups
Alumni start-ups
The Extension Fund will seek to invest in three distinct sources of commercial opportunity at UQ: companies initiated by UQ students through and outside of the UQ Ventures ilab program; through alumni-generated start-ups and those derived as outcomes of UQ research.
Where appropriate, the Extension Fund may co-invest alongside other parties. These co-investors may be third party entities and may be related to or associated with UniQuest.
The Extension Fund has a broad investment mandate, which is not limited to any particular sector, industry or business model.
The ideal investment opportunity
The following characteristics would constitute the 'ideal investment opportunity', although we acknowledge that such may not be available in the UQ marketplace - especially with student and early stage projects and start-up opportunities
A new technology
or a novel application of technology with potential to drive disruption within a defined market sector
Strong early market validation
where possible evidenced by the business having already generated its first commercial revenue
Founders with exceptional credentials
in terms of specific industry expertise or prior experience in early-stage, high-growth companies
A business model
that delivers (or is likely to deliver) attractive and sustainable unit economics
A target market
that is very large, growing and well-defined
Potential for sustained revenue growth
over the long term
A credible path
for the Extension Fund to exit its investment within a horizon commensurate with the opportunity
Further information
Download a brochure for more information. We have information tailored for potential investors and investees.
Contact us
Please contact us if you would like further details.
In any initial communication, please only provide non-confidential information.
Impact
$1b+
Raised to take university technology to market
150+
Active licence agreements
$70b+
Gross product sales of licensed
UQ technologies
$961m+
In revenue returned to UQ since 2002
125+
Companies created from UQ’s intellectual property portfolio
360+
Granted US patents
Researcher Journeys
Read about how UQ researchers have partnered with UniQuest to deliver solutions for a better world.
Gardasil®: A global solution to eradicating cervical cancer
From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to a decrease of approximately 90 per cent in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.
Encapsulated probiotic drink a world first
The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.
Bringing the benefits of positive parenting and healthy communities to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.
MRI scan technology is saving lives around the world
UQ’s innovative technology, which is used in most of the world’s MRI machines, has helped more than 8 billion people across the globe.
UQ technology with the power to revolutionise global vaccine delivery
Nanopatch™ technology developed by Professor Mark Kendall could have a global impact by improving vaccines so they no longer have to be administered by needle and syringe.
A smartphone app helping doctors and patients breathe easier
Just one cough and a simple and inexpensive new smartphone technology can instantly and accurately identify respiratory diseases.
UQ Research Impact
UQ research creates value that translates into impact for our local community, Australian society and in far-reaching places around the globe. UniQuest partners with UQ researchers to commercialise their research ideas.
Contact our team
UniQuest commercialises UQ research to create change. Speak to us about commercialising your research ideas today.